Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Cost-effectiveness of gene-expression profiling for tumor-site origin.

Hornberger J, Degtiar I, Gutierrez H, Shewade A, Henner WD, Becker S, Varadhachary G, Raab S.

Value Health. 2013 Jan-Feb;16(1):46-56. doi: 10.1016/j.jval.2012.09.005. Erratum in: Value Health. 2013 Mar-Apr;16(2):452. Varadachary, Gauri [corrected to Varadhachary, Gauri].

PMID:
23337215
[PubMed - indexed for MEDLINE]
2.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

PMID:
17999840
[PubMed - indexed for MEDLINE]
Free Article
3.

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.

PMID:
16545208
[PubMed - indexed for MEDLINE]
Free Article
4.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
5.

Clinical utility of gene-expression profiling for tumor-site origin in patients with metastatic or poorly differentiated cancer: impact on diagnosis, treatment, and survival.

Nystrom SJ, Hornberger JC, Varadhachary GR, Hornberger RJ, Gutierrez HR, Henner DW, Becker SH, Amin MB, Walker MG.

Oncotarget. 2012 Jun;3(6):620-8.

PMID:
22689213
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients: a Canadian payer perspective.

Vegter S, Tolley K, Keith MS, Lok CE, Soroka SD, Morton AR.

Clin Ther. 2012 Jul;34(7):1531-43. doi: 10.1016/j.clinthera.2012.06.006. Epub 2012 Jun 27.

PMID:
22742885
[PubMed - indexed for MEDLINE]
7.

Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model.

Yang M, Rajan S, Issa AM.

Cancer. 2012 Oct 15;118(20):5163-70. doi: 10.1002/cncr.27443. Epub 2012 Feb 22.

PMID:
22359236
[PubMed - indexed for MEDLINE]
Free Article
8.

Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation.

Hislop J, Quayyum Z, Elders A, Fraser C, Jenkinson D, Mowatt G, Sharma P, Vale L, Petty R.

Health Technol Assess. 2011 Jun;15(25):1-178. doi: 10.3310/hta15250. Review.

PMID:
21689502
[PubMed - indexed for MEDLINE]
Free Article
9.

Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis.

Hillner BE, Weeks JC, Desch CE, Smith TJ.

J Clin Oncol. 2000 Jan;18(1):72-9.

PMID:
10623695
[PubMed - indexed for MEDLINE]
Free Article
10.

The cost-effectiveness of testing for hepatitis C in former injecting drug users.

Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.

Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.

PMID:
16948891
[PubMed - indexed for MEDLINE]
Free Article
11.

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.

Angus DC, Linde-Zwirble WT, Clermont G, Ball DE, Basson BR, Ely EW, Laterre PF, Vincent JL, Bernard G, van Hout B; PROWESS Investigators.

Crit Care Med. 2003 Jan;31(1):1-11.

PMID:
12544986
[PubMed - indexed for MEDLINE]
12.

Cost effectiveness of lopinavir/ritonavir compared with atazanavir in antiretroviral-naive patients: modelling the combined effects of HIV and heart disease.

Simpson KN, Luo MP, Chumney EC, King MS, Brun S.

Clin Drug Investig. 2007;27(1):67-74.

PMID:
17177581
[PubMed - indexed for MEDLINE]
13.

Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.

Mullins CD, Hsiao FY, Onukwugha E, Pandya NB, Hanna N.

Cancer. 2012 Jun 15;118(12):3173-81. doi: 10.1002/cncr.26613. Epub 2011 Oct 21.

PMID:
22020739
[PubMed - indexed for MEDLINE]
Free Article
14.

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis.

Forbes JF, Adam DJ, Bell J, Fowkes FG, Gillespie I, Raab GM, Ruckley CV, Bradbury AW; BASIL trial Participants.

J Vasc Surg. 2010 May;51(5 Suppl):43S-51S. doi: 10.1016/j.jvs.2010.01.076.

PMID:
20435261
[PubMed - indexed for MEDLINE]
Free Article
15.

Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B).

Reynolds MR, Magnuson EA, Wang K, Lei Y, Vilain K, Walczak J, Kodali SK, Lasala JM, O'Neill WW, Davidson CJ, Smith CR, Leon MB, Cohen DJ; PARTNER Investigators.

Circulation. 2012 Mar 6;125(9):1102-9. doi: 10.1161/CIRCULATIONAHA.111.054072. Epub 2012 Feb 3.

PMID:
22308299
[PubMed - indexed for MEDLINE]
Free Article
16.

Gene expression profiling and breast cancer care: what are the potential benefits and policy implications?

Oestreicher N, Ramsey SD, Linden HM, McCune JS, van't Veer LJ, Burke W, Veenstra DL.

Genet Med. 2005 Jul-Aug;7(6):380-9.

PMID:
16024969
[PubMed - indexed for MEDLINE]
17.

Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer.

Glimelius B, Hoffman K, Graf W, Haglund U, Nyrén O, Påhlman L, Sjödén PO.

Ann Oncol. 1995 Mar;6(3):267-74.

PMID:
7542021
[PubMed - indexed for MEDLINE]
18.

Economic implications of 21-gene breast cancer risk assay from the perspective of an Israeli-managed health-care organization.

Klang SH, Hammerman A, Liebermann N, Efrat N, Doberne J, Hornberger J.

Value Health. 2010 Jun-Jul;13(4):381-7. doi: 10.1111/j.1524-4733.2010.00724.x. Epub 2010 Apr 15.

PMID:
20412544
[PubMed - indexed for MEDLINE]
19.

The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation.

Loveman E, Jones J, Hartwell D, Bird A, Harris P, Welch K, Clegg A.

Health Technol Assess. 2010 Mar;14(19):1-204. doi: 10.3310/hta14190. Review.

PMID:
20356561
[PubMed - indexed for MEDLINE]
Free Article
20.

Analysis of costs associated with administration of intravenous single-drug therapies in metastatic breast cancer in a U.S. population.

Kruse GB, Amonkar MM, Smith G, Skonieczny DC, Stavrakas S.

J Manag Care Pharm. 2008 Nov-Dec;14(9):844-57.

PMID:
19006441
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk